Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples

Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples

Feb 11, 2021
|
staff reporter

NEW YORK – Roche announced Thursday that its Cobas BKV test received 510(k) clearance from the US Food and Drug Administration for use with stabilized urine samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

  2. Cue Health Nabs CE Mark for Molecular Point-of-Care COVID-19 Test

  3. Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.